A carregar...
Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis
INTRODUCTION: This meta-analysis compares the effectiveness and safety of tumor necrosis factor α (TNF-α) antibodies (infliximab, adalimumab and certolizumab) with either a placebo or each of them in the treatment of Crohn's disease (CD). MATERIAL AND METHODS: A systematic review of literature...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3832823/ https://ncbi.nlm.nih.gov/pubmed/24273556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2013.38670 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|